Rock Creek Pharmaceuticals Inc. (fka RCPIQ)

[RJFL]

Fair enough, I agree I want to see additional studies, but marginal to me means not good results - the thyroid stuff is definitely not marginal, that's why the authors felt additional/continued assessment was warranted. I think the other anecdotal results reported by users are indicative of a growing tangential body of evidence information that is what has the FDA's knickers in a knot. If I a thyroid problem I would definitely be using it. In the internet age word gets around quickly and people draw their own conclusions, that's why the FDA is uncomfortable since the study referenced was a double blind study typical of one done by a pharmaceutical company. Good investing..